58 results
8-K
EX-99.1
INCY
Incyte Corp.
20 Oct 14
Incyte Appoints David Gryska as Executive Vice President and Chief Financial Officer
12:00am
is an exciting, innovative company with tremendous potential. I share its commitment to become a leading oncology company capable of bringing forward
8-K
EX-99.1
INCY
Incyte Corp.
25 Aug 00
Current report
12:00am
with innovative
approaches like the recently announced www.incyte.com, we look forward
8-K
EX-99.1
INCY
Incyte Corp.
12 Jan 15
Incyte and Agenus Announce Global Alliance to Develop Novel Immuno-Oncology Antibodies
12:00am
. This innovative cell-displayed expression platform permits the rapid generation of fully human and humanized therapeutic antibodies with high affinity
PX14A6G
Flaherty Dundas I
24 Apr 20
Letter to shareholders
1:22pm
in shaping a more successful, innovative company with new medicines that rarely fail late-stage trials.
New products and company growth flow from
8-K
EX-99.1
INCY
Incyte Corp.
16 Jan 20
MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab
4:09pm
) is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of exceptional, innovative therapies
8-K
EX-99.1
u6xp7bns lb
1 May 18
Incyte Reports 2018 First-Quarter Financial Results and Updates on Key Clinical Programs
7:09am
8-K
EX-99.1
161xqta33cg6gp
31 Jul 18
Incyte Reports 2018 Second Quarter Financial Results and Updates on Key Clinical Programs
12:00am